However, increased insight into the specific mechanisms of O-GlcNAcylation of Tau is required to elucidate if the hyperphosphorylation in AD is in fact a cause or a consequence of decreased O-GlcNAcylation. The gene discussed is MAPT; the disease is Alzheimer disease.